Have £4k to spend on your ISA? 3 FTSE 100 dividend stocks that could surge in 2020

Looking to get rich off Footsie-quoted income shares? These heroes could be just what you need as we head into 2020, says Royston Wild.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In worrying times like these it’s good to have exposure to some classic safe-haven assets. Holding gold and gold-producing stocks is one great idea as a hedge against the multitude of geopolitical and macroeconomic issues heading into 2020, but of course it’s not the only way to play volatile markets.

With this in mind I reckon BAE Systems (LSE: BA) is a share that’s in good shape to rise next year. It’s already up 17% in 2019 versus the 8% rise in the broader FTSE 100, paying testament to the defence sector’s reputation as a lifeboat in troubled times.

Humans simply can’t resist waging war among themselves, which gives this particular business, exceptional earnings visibility. BAE System’s provides a wide variety of industry-leading tech. And what’s more, fresh military action in Syria and ongoing tension between the US and Iran – sagas that have led President Trump to suggest possible intervention by US armed forces – could in particular cause a spike in the company’s share price next year.

A modest forward price-to-earnings ratio of 11 times for 2020, along with a bulky corresponding 4.5% dividend yield certainly gives the weapon-builder plenty more scope to rise.

Drink it in

Diageo (LSE: DGE) is another blue chip that’s outperformed the wider Footsie so far this year. The beverages behemoth’s share price is up 12% since the turn of January.

Like BAE Systems, this particular business is also a safe-haven in troubled times. It doesn’t matter, broadly speaking, what horrors are developing in the global economy. Thanks to the striking popularity of products like Captain Morgan rum, Smirnoff vodka, and Guinness stout, profits can still be relied on to grow.

This was perfectly evident in latest trading guidance last month in which Diageo advised that organic net sales would rise a healthy 5% in the fiscal year to June 2020.

Critically for income chasers, this splendid earnings visibility has enabled the company to consistently raise annual dividends for donkeys’ years now. And unsurprisingly, City analysts expect further progress on this front, leaving an inflation-topping yield of 2.3%.

The right medicine

If you’re not content with guaranteed (well, almost) dividend growth and want big yields today, then GlaxoSmithKline (LSE: GSK) may be more up your street. The annual dividend is expected to remain locked at 80p through to the close of 2020 but the good news is that this offers a bulging 4.8% yield.

Healthcare-related stocks are of course more of those classic flight-to-safety assets and this has helped Glaxo rise 13% in value since the start of the year. But this isn’t the whole story. Investors have also been tempted in by the rate at which Glaxo’s new medicines are blasting off, not to mention the release of significant regulatory approvals and key testing milestones. The latest of these in late September revealed some terrific study data for its zejula ovarian cancer battler.

With a packed product pipeline and a terrific track record of getting its drugs from lab bench to pharmacy shelf, I’m expecting another year of progress for Glaxo’s share price. A low forward P/E ratio of 14.3 times gives it space to rise, too.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild owns shares of Diageo. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »